Thomas Reiser: How Can Medical and Healthcare Associations Stay Impactful in a Changing Environment?
Thomas Reiser, Former Executive Director at the International Society on Thrombosis and Haemostasis, reposted from ESAE on LinkedIn adding:
”What are the strategies that will keep medical-scientific and healthcare associations impactful and successful in an ever shifting environment full of challenges and opportunities?
I very much look forward to discussing what it will take to prepare for what lies ahead and stay relevant with my talented co-panelists at the upcoming ESAE – European Society of Association Executives Association Summit on March 26 in Brussels.
If you are leading a medical-professional or healthcare organization you don’t want to miss this session!”
Quoting European Society of Association Executives (ESAE)‘s post:
”Will Health Associations still be around in 20 years?
Demographics are shifting.
The shortage of health professionals is growing. Fewer young people are choosing medical careers.
What does this mean for membership-based medical societies? For congress participation?
For volunteer engagement? For long-term societal impact?
At EAS26, ESAE’s Health Community is bringing this urgent conversation to the stage in an interactive session that will explore how Health Associations can prepare for what lies ahead, from revenue diversification and congress strategy to sponsorship models and policy influence.
We are pleased to welcome as speakers:
- Davi Kaur, CEO, European Society for Emergency Medicine
- Frédéric Destrebecq, Executive Director, European Brain Foundation
- Alessandro Jacques Cortese, CEO, European Society for Radiotherapy and Oncology (ESTRO)
- Thomas Reiser, Industry Expert
If you work in the health Association space, this is not a conversation to miss at the European Association Summit!
You haven’t secured your EAS26 ticket yet?
Now it’s the time.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly